Nobilis Therapeutics to Present at CapCon 2020 Venture Conference
30. Oktober 2020 09:00 ET
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, a late stage biotechnology company that is developing a drug-device combination for treatment of psychiatric disorders will...
Nobilis Therapeutics’ NBTX-001 shows promise in treatment of patients with Panic Disorder
14. Juni 2017 13:34 ET
|
Nobilis Therapeutics, Inc.
PORTLAND, Ore., June 14, 2017 (GLOBE NEWSWIRE) -- Nobilis Therapeutics, Inc. announced today that the results of the clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in...